Wyeth discontinues Suprax
Executive Summary
Wyeth will continue to sell oral antimicrobial Suprax (cefixime) suspension through March or until company's supply is depleted, following decision to discontinue the product. Cefixime lost patent protection on Nov. 10; Wyeth said it had always intended to cease marketing the drug once it lost exclusivity...